Tau in Late-Life Depression: A Systematic Review and Meta-Analysis (Q38920533)

7 September 2017

0 references

1 reference

title

Tau in Late-Life Depression: A Systematic Review and Meta-Analysis (English)

1 reference

7 September 2017

Ariel Graff-Guerrero

0 references

author name string

Eric E Brown

1 reference

7 September 2017

Yusuke Iwata

1 reference

7 September 2017

Jun Ku Chung

1 reference

7 September 2017

Philip Gerretsen

1 reference

7 September 2017

publication date

4 August 2016

1 reference

Journal of Alzheimer's Disease

7 September 2017

published in

1 reference

7 September 2017

1 reference

7 September 2017

1 reference

7 September 2017

page(s)

615-633

1 reference

The molecular neurobiology of depression

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

Depression as a risk factor for Alzheimer disease: the MIRAGE Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

Maintenance treatment of depression in old age: a randomized, double-blind, placebo-controlled evaluation of the efficacy and safety of donepezil combined with antidepressant pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

Amyloid-beta and depression in healthy older adults: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

Depression in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

Depression in late life: review and commentary

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

Affective disorders and risk of developing dementia: systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

Depression subtypes and 5-year risk of dementia and Alzheimer disease in patients aged 70 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

Neuropsychological differences between late-onset and recurrent geriatric major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

Does the risk of developing dementia increase with the number of episodes in patients with depressive disorder and in patients with bipolar disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

Neuropathologic correlates of late-onset major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

Revising the definition of Alzheimer's disease: a new lexicon.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

Tau in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

Propagation of tau pathology in a model of early Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

Staging of Alzheimer's disease-related neurofibrillary changes

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

Memory and mental status correlates of modified Braak staging.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

Tau and p-tau as CSF biomarkers in dementia: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

Cerebrospinal fluid tau protein shows a better discrimination in young old (<70 years) than in old old patients with Alzheimer's disease compared with controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

Cerebrospinal fluid tau levels in Alzheimer's disease are elevated when compared with vascular dementia but do not correlate with measures of cerebral atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

Differentiation of geriatric major depression from Alzheimer's disease with CSF tau protein phosphorylated at threonine 231.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

Measurement of thirteen biological markers in CSF of patients with Alzheimer's disease and other dementias

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

The relationship between cerebrospinal fluid biomarkers and depression in elderly women

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

Cerebrospinal fluid biomarkers in Alzheimer's disease and geriatric depression: preliminary findings from Brazil.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

Lower CSF amyloid beta peptides and higher F2-isoprostanes in cognitively intact elderly individuals with major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

Reduced cerebrospinal fluid levels of brain-derived neurotrophic factor is associated with cognitive impairment in late-life major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

d-serine levels in Alzheimer's disease: implications for novel biomarker development

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

Sensitivity, specificity, and stability of CSF-tau in AD in a community-based patient sample

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

The diagnostic value of cerebrospinal fluid tau protein in dementing and nondementing neuropsychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

Cerebrospinal fluid TAU protein and amyloid beta42 in mild cognitive impairment: prediction of progression to Alzheimer's disease and correlation with the neuropsychological examination

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

Blood-based neurochemical diagnosis of vascular dementia: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

Hypocretin in cerebrospinal fluid is positively correlated with Tau and pTau

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

Combined CSF tau, p-tau181 and amyloid-beta 38/40/42 for diagnosing Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

Antipsychotic medication is associated with selective alterations in ventricular cerebrospinal fluid Aβ 40 and tau in patients with intractable unipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

Mapping correlations between ventricular expansion and CSF amyloid and tau biomarkers in 240 subjects with Alzheimer's disease, mild cognitive impairment and elderly controls

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

Plasma biomarkers of depressive symptoms in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

Cognitive decline from estimated premorbid status predicts neurodegeneration in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

Subjective cognitive decline is related to CSF biomarkers of AD in patients with MCI.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

Neuropsychiatric correlates of cerebrospinal fluid biomarkers in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

Neurobiological correlates of depressive symptoms in people with subjective and mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

Protein binding in patients with late-life depression

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

Differential FDDNP PET patterns in nondemented middle-aged and older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

Depression and anxiety symptoms are associated with cerebral FDDNP-PET binding in middle-aged and older nondemented adults

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

Structural brain changes associated with depressive symptoms in the elderly with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

Cognitive impairment in depression is not associated with neuropathologic evidence of increased vascular or Alzheimer-type pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

Neuritic pathology is lacking in the entorhinal cortex, subiculum and hippocampus in middle-aged adults with schizophrenia, bipolar disorder or unipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

Neuropathological study of the dorsal raphe nuclei in late-life depression and Alzheimer's disease with and without depression

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

Depression in the elderly: pathological study of raphe and locus ceruleus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

Increased neurofibrillary tangles in patients with Alzheimer disease with comorbid depression

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

Neuropathological correlates of late-life depression in older people

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

The neuropathology of aminergic nuclei in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

Increased hippocampal plaques and tangles in patients with Alzheimer disease with a lifetime history of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

Brainstem aminergic nuclei and late-life depressive symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

Clinical-pathologic study of depressive symptoms and cognitive decline in old age

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

Alzheimer's disease pathology does not mediate the association between depressive symptoms and subsequent cognitive decline

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

Depressive symptoms, clinical AD, and cortical plaques and tangles in older persons

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

The CES-D Scale: A Self-Report Depression Scale for Research in the General Population

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

Memory complaints are related to Alzheimer disease pathology in older persons

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

PET of brain amyloid and tau in mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

Neuroimaging correlates of pathologically defined subtypes of Alzheimer's disease: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

Relationship between tau pathology and neuroinflammation in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

Amyloid Hypothesis: Is There a Role for Antiamyloid Treatment in Late-Life Depression?

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

Plasma and cerebrospinal fluid amyloid-β levels in late-life depression: A systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

Changes in tau phosphorylation levels in the hippocampus and frontal cortex following chronic stress

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

Pragmatism Instead of Mechanism: A Call for Impactful Biological Psychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

Brain stem serotonin-synthesizing neurons in Alzheimer's disease: a clinicopathological correlation

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

Distinguishing between neurodegenerative disease and disease-free aging: correlating neuropsychological evaluations and neuropathological studies in centenarians

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

Evaluation of CSF Biomarkers as Predictors of Alzheimer's Disease: A Clinical Follow-Up Study of 4.7 Years

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

CSF markers in Alzheimer disease patients are not related to the different degree of cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

Geriatric depression: Age of onset and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160401

21 January 2018

Identifiers

DOI

10.3233/JAD-160401

1 reference

7 September 2017

1 reference